Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathaniel J Moorman

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
Journal of Virology|September 27, 2023
Human cytomegalovirus attenuates AKT activity by destabilizing insulin receptor substrate proteinsAnthony J Domma, Lauren A Henderson, Felicia D Goodrum, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2025
RNA-targeted proteomics identifies YBX1 as critical for efficient HCMV mRNA translationRebekah J Dickmander, Erik M Lenarcic, John D Sears, et al.
Journal of Virology|August 16, 2020
Two Genetic Differences between Closely Related Zika Virus Strains Determine Pathogenic Outcome in MiceDerek L Carbaugh, Shuntai Zhou, Wes Sanders, et al.
Proteomics|April 21, 2015
Human cytomegalovirus TRS1 protein associates with the 7-methylguanosine mRNA cap and facilitates translationBenjamin Ziehr, Erik Lenarcic, Heather A Vincent, et al.
Journal of Virology|October 29, 2024
Protein phosphatase 1 suppresses PKR/EIF2α signaling during human cytomegalovirus infectionErik M Lenarcic, Andrew E Hale, Heather A Vincent, et al.
Cell Host & Microbe|April 15, 2008
Human cytomegalovirus protein UL38 inhibits host cell stress responses by antagonizing the tuberous sclerosis protein complexNathaniel J Moorman, Ileana M Cristea, Scott S Terhune, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 23, 2019
The Ex Vivo Treatment of Donor T Cells with Cosalane, an HIV Therapeutic and Small-Molecule Antagonist of CC-Chemokine Receptor 7, Separates Acute Graft-versus-Host Disease from Graft-versus-Leukemia Responses in Murine Hematopoietic Stem Cell Transplantation ModelsKenneth A Fowler, Kelin Li, Christopher B Whitehurst, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2019
Alternative promoters drive human cytomegalovirus reactivation from latencyDonna Collins-McMillen, Mike Rak, Jason C Buehler, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2020
FOXO transcription factors activate alternative major immediate early promoters to induce human cytomegalovirus reactivationAndrew E Hale, Donna Collins-McMillen, Erik M Lenarcic, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2024
Identification of 4-(6-((2-methoxyphenyl)amino)pyrazin-2-yl)benzoic acids as CSNK2A inhibitors with antiviral activity and improved selectivity over PIM3Kareem A Galal, Andreas Krämer, Benjamin G Strickland, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Journal of Virology|September 27, 2023
Human cytomegalovirus attenuates AKT activity by destabilizing insulin receptor substrate proteinsAnthony J Domma, Lauren A Henderson, Felicia D Goodrum, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2025
RNA-targeted proteomics identifies YBX1 as critical for efficient HCMV mRNA translationRebekah J Dickmander, Erik M Lenarcic, John D Sears, et al.
Journal of Virology|August 16, 2020
Two Genetic Differences between Closely Related Zika Virus Strains Determine Pathogenic Outcome in MiceDerek L Carbaugh, Shuntai Zhou, Wes Sanders, et al.
Proteomics|April 21, 2015
Human cytomegalovirus TRS1 protein associates with the 7-methylguanosine mRNA cap and facilitates translationBenjamin Ziehr, Erik Lenarcic, Heather A Vincent, et al.
Journal of Virology|October 29, 2024
Protein phosphatase 1 suppresses PKR/EIF2α signaling during human cytomegalovirus infectionErik M Lenarcic, Andrew E Hale, Heather A Vincent, et al.
Cell Host & Microbe|April 15, 2008
Human cytomegalovirus protein UL38 inhibits host cell stress responses by antagonizing the tuberous sclerosis protein complexNathaniel J Moorman, Ileana M Cristea, Scott S Terhune, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 23, 2019
The Ex Vivo Treatment of Donor T Cells with Cosalane, an HIV Therapeutic and Small-Molecule Antagonist of CC-Chemokine Receptor 7, Separates Acute Graft-versus-Host Disease from Graft-versus-Leukemia Responses in Murine Hematopoietic Stem Cell Transplantation ModelsKenneth A Fowler, Kelin Li, Christopher B Whitehurst, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2019
Alternative promoters drive human cytomegalovirus reactivation from latencyDonna Collins-McMillen, Mike Rak, Jason C Buehler, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2020
FOXO transcription factors activate alternative major immediate early promoters to induce human cytomegalovirus reactivationAndrew E Hale, Donna Collins-McMillen, Erik M Lenarcic, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2024
Identification of 4-(6-((2-methoxyphenyl)amino)pyrazin-2-yl)benzoic acids as CSNK2A inhibitors with antiviral activity and improved selectivity over PIM3Kareem A Galal, Andreas Krämer, Benjamin G Strickland, et al.
Pageof 11